Investment Bankers for the
Life Sciences Industry
-
Our Focus
BroadOak Capital Partners, LLC is a privately held investment bank with a comprehensive focus on the life sciences industry. We offer advisory services including mergers and acquisitions, divestitures, business combinations, capital formation, valuations and fairness opinions.
Learn More -
The BroadOak Fund
Through the firm’s affiliate, The BroadOak Fund, we actively seek opportunities to invest growth capital into companies within our industry focus.
Learn More -
BroadOak Partners provides a wide array of investment banking advisory services:
- Mergers and Acquisitions
- Sell-side and Buy-side Advisory
- Equity, Debt and Mezzanine Capital Formation
- Leveraged Transactions; Recapitalizations
- Valuations and Fairness Opinions
- Financial Strategic Advisory Services
-
Linkage Sells to Thermo Fisher
July 2017BroadOak Partners advises Linkage Biosciences on the sale of the company to Thermo Fisher Scientific. Linkage Biosciences is a provider of molecular…
-
Trinean Sells to Unchained Labs
June 2017BroadOak Partners advises Trinean on the sale of the company to Unchained Labs. Trinean is a provider of instrumentation and analytical software…
-
LabConnect Announces $24.5 Million Financing Round
June 2017BroadOak Partners acted as the exclusive placement agent for LabConnect’s $24.5 million Series A financing…
-
Rubicon Genomics Sells to Takara Bio
January 2017BroadOak Partners advises Rubicon Genomics on the sale of the company to Takara Bio. Rubicon Genomics is a provider high quality, nucleic acid library…
-
MTI-GlobalStem Sells to Thermo Fisher Scientific
November 2016BroadOak Partners advises MTI-GlobalStem on the sale of the company to Thermo Fisher Scientific Inc. MTI-GlobalStem is a provider of leading-edge technology and reagents for…
-
Brooks Automation Announces the Acquisition of Cool Lab, LLC
November 2016BioCision, LLC, a BroadOak portfolio company, has divested its Cool Lab subsidiary to Brooks Automation, Inc. (Nasdaq:BRKS). Cool Lab, LLC provides…
-
BioCision Announces the Formation of MedCision
November 2016BroadOak portfolio company, BioCision, LLC announces the formation of MedCision Inc, an independent company focused on the automation of pre-clinical and clinical…
-
Antibodies-online GmbH Raises Growth Capital
October 2016BroadOak provided growth capital financing to antibodies-online GmbH, a leading digital marketing and e-commerce platform for the distribution of life sciences research products…
-
GTCR and Maravai Complete Acquisitions of TriLink Biotechnologies and Cygnus Technologies
October 2016BroadOak Partners advises Maravai LifeSciences, Inc., a partnership including GTCR, a leading private equity firm…
-
Bioo Scientific Sells to PerkinElmer
July 2016BroadOak Partners advises Bioo Scientific Corporation on the sale of the company to PerkinElmer, Inc. Bioo Scientific is a leading provider of food safety tests sold into food…
-
Clarity Sells Ophthalmic Imaging Business to Natus Medical
July 2016BroadOak Partners advises Clarity Medical Systems, a leading provider of clinical ophthalmic technologies, on the…
-
GTCRaand Maravai Complete Strategic Equity Investment in Vector Laboratories
April 2016BroadOak Partners advises Maravai LifeSciences, Inc., a partnership including GTCR, a leading private equity firm,…
-
LabConnect Raises $4.0 million to Fund Growth Targets
March 2016The BroadOak Fund III has completed a $4.0 million investment into LabConnect, LLC, a leading global provider of central…
-
AdvanDx Sells to OpGen; OpGen Secures $6M in Financing from Merck GHI Fund
July 2015BroadOak Partners advises AdvanDx, a developer of rapid molecular tests for the diagnosis and treatment of…
-
Rubicon Genomics Raises $2m to Support Strong Growth Momentum
July 2015BroadOak Capital Partners led the round, joined by Research Corporation Technologies. The Ann Arbor, Michigan-based…
-
Diagnostic Biosystems Raises Growth Capital to Support Continued Expansion
May 2015The BroadOak Fund, an affiliate of BroadOak Capital Partners, provided financing to Diagnostic Biosystems to support…
-
Spectra Analysis Instruments, Inc. Sells to DANI Instruments Group
February 2015BroadOak Capital Partners, through its affiliate the BroadOak Fund, successfully exited its investment in Spectra Analysis Instruments, Inc. upon sale…
-
Orflo Closes Growth Capital Investment
February 2015BroadOak Capital Partners, through its affiliate the BroadOak Fund, lead a $3.0 million financing for Orflo Technologies, an innovator of cell analysis…
-
BroadOak Fund Provides Acquisition Financing to BioInformatics
September 2014The BroadOak Fund, an affiliate of BroadOak Capital Partners, provided financing to BioInformatics for the acquisition of Strategic Directions International, Inc.…
-
Stemgent Sells iPS Cell Business to ReproCELL
September 2014BroadOak Partners advises Stemgent, a leader in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular…
-
Asuragen Sells Diagnostic Tests to PDI
August 2014BroadOak Partners advises Asuragen, a molecular diagnostics company, on the sale of its miRInform Thyroid™ and Pancreas tests to PDI, Inc.’s subsidiary, Interpace Diagnostics.
-
EdgeBio Sells to StoneCalibre
July 2014BroadOak Partners advises Edge Biosystems, a specialized manufacturer and distributor of sample preparation and clean-up products for use in DNA sequencing, on its sale to StoneCalibre.
-
BioCision Closes $4M Equity Financing with Brooks Automation
March 2014BroadOak Partners advises BioCision in a strategic investment by Brooks Automation to accelerate commercial momentum. In addition, the companies entered into a collaboration agreement to jointly develop products that support transport, storage and processing of biomaterials.
-
ABL Sells Preclinical Services Business to BIOQUAL
February 2014BroadOak Partners advises Advanced Bioscience Laboratories (“ABL”), a leading life science contract research and manufacturing organization, on the sale of its in-vivo preclinical business to BIOQUAL, Inc.
-
EdgeBio Sells Sequencing Services Business to BioReference Laboratories
August 2013BroadOak Partners advises EdgeBio, a research reagents and sequencing services company, on the sale of its genetic sequencing services business to BioReference Laboratories, Inc.
-
SDIX Sells Life Science Business To OriGene Technologies
July 2013BroadOak Partners advises SDIX, an antibody focused biotechnology company, on the sale of the assets of its Life Science business to OriGene Technologies, Inc. for $16 million. BroadOak Partners also rendered a fairness opinion to the board of directors of SDIX.
-
UVP sells to Analytik Jena
April 2013BroadOak Partners advises UVP LLC on the sale of the company to Analytik Jena AG. UVP is a leading developer and manufacturer of bioimaging systems and ultraviolet products for the academic, pharmaceutical and biotechnology markets and a portfolio company of Carlyle Enterprises.
-
SeraCare Life Sciences divests BioServices business
December 2012BroadOak Partners advises SeraCare Life Sciences, a diagnostics products company, on the sale of its BioServices business, a division which provides biorepository and sample handling services, to Precision Bioservices, Inc.
-
SDIX divests Food Safety
October 2012
and GMO businessesBroadOak Partners advises SDIX, an antibody focused biotechnology company, on the sale of its Food Safety and GMO businesses to Romer Labs.
-
Carestream Health divests preclincial in-vivo imaging business
September 2012BroadOak Partners advises Carestream Health, Inc., a leader in healthcare imaging systems and films, on the sale of the in vivo business of Carestream Molecular Imaging, a division which provides preclinical…
-
BioCision closes growth capital investment
April 2012BroadOak Capital Partners, through its affiliate the BroadOak Fund, participated in a financing for BioCision, LLC, a bench-top laboratory tools provider, to help fund the company’s growth.
